Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.

PubWeight™: 9.14‹?› | Rank: Top 0.1%

🔗 View Article (PMC 196882)

Published in Proc Natl Acad Sci U S A on September 05, 2003

Authors

Hwei-Ling Cheng1, Raul Mostoslavsky, Shin'ichi Saito, John P Manis, Yansong Gu, Parin Patel, Roderick Bronson, Ettore Appella, Frederick W Alt, Katrin F Chua

Author Affiliations

1: Howard Hughes Medical Institute, Children's Hospital, Center for Blood Research, and Department of Genetics, Harvard University Medical School, Boston, MA 02115, USA.

Articles citing this

(truncated to the top 100)

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J (2004) 11.00

Modes of p53 regulation. Cell (2009) 9.31

Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol (2010) 8.55

Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60

Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell (2008) 6.93

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell (2005) 6.79

The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell (2008) 6.44

Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2011) 6.36

miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A (2008) 6.24

SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell (2008) 5.76

Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol (2005) 5.54

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A (2008) 5.48

Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A (2008) 5.21

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02

A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature (2008) 4.43

A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature (2010) 4.39

Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09

MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab (2012) 3.69

SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One (2008) 3.66

Retracted SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell (2010) 3.58

Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev (2008) 3.46

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell (2008) 3.38

Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol (2006) 3.37

SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34

Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev (2006) 3.31

Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet (2010) 3.29

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol (2010) 3.27

How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer (2008) 3.17

Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron (2010) 3.15

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev (2006) 3.12

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A (2004) 3.06

Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol (2004) 3.00

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell (2012) 2.96

Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest (2010) 2.92

SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci (2009) 2.80

SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell (2011) 2.73

SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell (2008) 2.67

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev (2010) 2.55

p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med (2010) 2.54

Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype. Cell Metab (2015) 2.48

SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell (2007) 2.42

mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev (2005) 2.37

Phosphorylation regulates SIRT1 function. PLoS One (2008) 2.30

SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol (2005) 2.24

Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov (2012) 2.22

Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19

Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol (2012) 2.12

Energetics, epigenetics, mitochondrial genetics. Mitochondrion (2009) 2.08

SIRT1: recent lessons from mouse models. Nat Rev Cancer (2010) 2.07

Sirt1-deficient mice exhibit an altered cartilage phenotype. Joint Bone Spine (2013) 2.06

Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol (2007) 2.04

The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest (2009) 2.02

Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol (2006) 2.02

Retracted SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci (2012) 2.00

Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev (2012) 1.99

Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev (2009) 1.97

Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol (2010) 1.94

Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys (2010) 1.91

Metabolic control of autophagy. Cell (2014) 1.90

Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest (2010) 1.90

Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab (2009) 1.89

SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci U S A (2009) 1.89

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci (2008) 1.88

SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem (2010) 1.86

Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem (2009) 1.86

SRT1720 improves survival and healthspan of obese mice. Sci Rep (2011) 1.81

Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest (2011) 1.80

High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab (2012) 1.77

miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) (2010) 1.76

Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci (2008) 1.75

Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J Clin Invest (2011) 1.74

Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J Neurosci (2010) 1.73

Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem (2010) 1.71

SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci (2010) 1.71

SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell (2013) 1.71

Neural tube defects. Annu Rev Neurosci (2014) 1.69

The impact of acetylation and deacetylation on the p53 pathway. Protein Cell (2011) 1.66

Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem (2010) 1.65

Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Endocrinology (2010) 1.65

SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab (2010) 1.64

The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest (2006) 1.62

p53-based cancer therapy. Cold Spring Harb Perspect Biol (2010) 1.62

Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci U S A (2008) 1.62

SIRT6 in DNA repair, metabolism and ageing. J Intern Med (2008) 1.61

Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol (2008) 1.57

NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J (2006) 1.57

The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Targets Ther (2013) 1.57

Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases. Mol Cell (2014) 1.56

NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1. Nat Struct Mol Biol (2015) 1.55

A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. Mol Cell (2011) 1.55

Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol Cell Proteomics (2012) 1.54

Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol Cell Biol (2011) 1.53

AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res (2012) 1.52

Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood (2011) 1.52

SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J Neurosci (2010) 1.51

Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis. Gastroenterology (2013) 1.50

Articles cited by this

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54

Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97

Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05

p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (1993) 13.46

Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun (2000) 9.09

A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell (2003) 8.34

DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev (1998) 7.78

Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell (1996) 7.70

Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol (1992) 7.23

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J (2002) 6.37

The mechanism and regulation of chromosomal V(D)J recombination. Cell (2002) 6.28

Sir2 links chromatin silencing, metabolism, and aging. Genes Dev (2000) 5.95

Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun (1999) 5.83

Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev (2000) 5.80

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46

Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem (2001) 5.43

The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol (2003) 5.38

The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol (2002) 5.37

Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (2000) 4.75

Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature (1997) 4.57

SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A (2002) 4.27

DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell (2000) 3.82

MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks. Cell (1999) 3.62

Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem (2002) 3.37

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J (2002) 3.29

The molecular biology of the SIR proteins. Gene (2001) 3.05

Mechanism and control of class-switch recombination. Trends Immunol (2002) 2.95

p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev (1998) 2.53

Function of the TCR alpha enhancer in alphabeta and gammadelta T cells. Immunity (1997) 2.51

NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae. Nature (2001) 2.42

Why is p53 acetylated? Cell (2001) 2.42

The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. Immunity (1996) 2.39

p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J (2000) 2.38

DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell (2002) 2.29

Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun (2003) 2.27

Mammalian hairy and Enhancer of split homolog 1 regulates differentiation of retinal neurons and is essential for eye morphogenesis. Neuron (1996) 2.22

Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci U S A (1999) 2.10

Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A (2002) 2.04

Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases. Trends Biochem Sci (2003) 2.03

NHEJ regulation by mating type is exercised through a novel protein, Lif2p, essential to the ligase IV pathway. Genes Dev (2001) 1.93

Nej1p, a cell type-specific regulator of nonhomologous end joining in yeast. Curr Biol (2001) 1.91

The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol Cancer Res (2003) 1.85

Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol (2002) 1.85

Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci U S A (2000) 1.80

Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol (2002) 1.70

DNA damage triggers disruption of telomeric silencing and Mec1p-dependent relocation of Sir3p. Curr Biol (1999) 1.64

The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ (1998) 1.52

Vax2 inactivation in mouse determines alteration of the eye dorsal-ventral axis, misrouting of the optic fibres and eye coloboma. Development (2002) 1.39

The proliferative and apoptotic activities of E2F1 in the mouse retina. Oncogene (2001) 1.00

Articles by these authors

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38

Projection of an immunological self shadow within the thymus by the aire protein. Science (2002) 12.15

ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature (2006) 9.30

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell (2006) 8.48

Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol (2007) 7.97

Recent progress in the biology and physiology of sirtuins. Nature (2009) 7.73

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J (2007) 7.30

SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell (2006) 6.79

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature (2010) 6.48

Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2011) 6.36

The mechanism and regulation of chromosomal V(D)J recombination. Cell (2002) 6.28

MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell (2006) 6.09

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell (2009) 6.09

IgH class switching and translocations use a robust non-classical end-joining pathway. Nature (2007) 6.05

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature (2008) 6.02

The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res (2005) 5.93

p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol (2004) 5.82

SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell (2008) 5.76

SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell (2008) 5.68

DNA repair, genome stability, and aging. Cell (2005) 5.52

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A (2008) 5.48

Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell (2003) 5.26

Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature (2003) 5.20

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11

Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A (2002) 5.07

Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol (2006) 4.32

Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell (2002) 4.29

53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol (2004) 4.14

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell (2005) 4.14

Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol (2004) 4.04

Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell (2012) 4.02

Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature (2004) 3.94

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet (2004) 3.89

Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell (2011) 3.81

Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A (2004) 3.74

Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell (2007) 3.68

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol (2002) 3.55

H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell (2006) 3.53

High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell (2004) 3.46

Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev (2008) 3.46

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J (2002) 3.45

SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell (2011) 3.33

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet (2002) 3.32

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J (2002) 3.29

The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol (2011) 3.21

Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab (2005) 3.15

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev (2006) 3.12

Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. Mol Ther (2011) 3.10

Activating Notch1 mutations in mouse models of T-ALL. Blood (2005) 3.08

Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature (2010) 3.03

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature (2012) 2.96

Mechanism and control of class-switch recombination. Trends Immunol (2002) 2.95

Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol (2007) 2.94

Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res (2006) 2.92

Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature (2003) 2.92

Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol Cell (2007) 2.88

Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol (2008) 2.85

Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab (2006) 2.82

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell (2012) 2.78

SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab (2010) 2.77

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev (2008) 2.74

Calorie restriction alters mitochondrial protein acetylation. Aging Cell (2009) 2.73

The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev (2003) 2.72

The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst) (2004) 2.72

The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature (2005) 2.63

CTCF-binding elements mediate control of V(D)J recombination. Nature (2011) 2.62

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev (2010) 2.55

SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature (2013) 2.52

SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) (2009) 2.50